Product Catalog
90+ peptides. One quality system.
Lyophilized vials at ≥99% HPLC purity, batch-specific COAs, sequence verification on request. Bulk pricing and OEM available.
Already know the peptide name? Browse the full A-Z directory.
57 SKUs · alphabetical · sticky letter strip · direct links to specs.
Browse by category
GH-Axis Peptides
CJC-1295, Sermorelin, Ipamorelin, GHRP-2/6, IGF-1 LR3, MGF, Tesamorelin, HGH and HGH-fragment 176-191. GHRH-receptor agonists, GHSR (ghrelin-receptor) agonists, and IGF-axis reagents for somatotropic-pathway research.
Browse
Cognitive & Neuropeptides
Semax, Selank, DSIP, Cerebrolysin, P21, Pinealon, Melatonin, VIP, Oxytocin, Kisspeptin-10. Neuropeptide reagents for cognitive, mood, sleep-architecture, social-behaviour, and HPG-axis research.
Browse
Khavinson Bioregulators
Admax, Cortagen, Cartalax, Cardiogen, Bronchogen, Crystagen, Prostamax, Vesugen — short peptide bioregulators developed by the Khavinson school. Tissue-specific research peptides with a literature base concentrated in Russian-language sources.
Browse
Other Research Peptides
Melanotan-1, Melanotan-2, PT-141, ACE-031, Adipotide-FTTP, EPO, HCG, HMG. Peptide and protein research reagents that operate outside the GH / cognitive / immune / mitochondrial / repair / longevity / Khavinson clusters.
Browse
Mitochondrial & Energy
MOTS-c, SS-31 (Elamipretide), AICAR, NAD+, 5-Amino-1MQ, SLU-PP-332. Mitochondrial-targeted peptides and small-molecule reagents for electron-transport, AMPK, sirtuin, and cellular-energetics research.
Browse
Immune & Anti-Inflammatory
KPV, LL-37, Thymalin, Thymosin α1, ARA-290. Immune-modulation, antimicrobial, and anti-inflammatory research peptides.
Browse
Tissue-Repair Peptides
BPC-157, TB-500 (thymosin β4 fragment), B7-33, PEG-MGF. Soft-tissue, tendon-ligament, gastrointestinal-mucosa, and vascular-repair research peptides.
Browse
Longevity & Senolytic
Epitalon, FoxO4-DRI, PNC-27. Telomere, senescence-clearance, and tumour-suppressor research peptides.
Browse
All products
57 peptides · live catalog
5-Amino-1MQ
≥99.0%NNMT inhibitor (5-Amino-1-methylquinolinium iodide)
- CAS
- 42464-96-0
- Vial
- 5 mg–50 mg
ACE-031 (ActRIIB-Fc Fusion)
≥99.0%ActRIIB-Fc decoy receptor fusion protein · myostatin pathway
- CAS
- —
- Vial
- 1 mg
19-mer
Adipotide (FTPP)
≥99.0%Prohibitin-targeting adipose vascular peptide
- CAS
- —
- Vial
- 2 mg–10 mg
ADMAX (Supplier Trade Name)
≥99.0%Supplier trade-name product · API to be confirmed
- CAS
- —
- Vial
- 5 mg · 10 mg
AICAR (Acadesine)
≥99.0%AMPK pathway activator · exercise mimetic research compound
- CAS
- 2627-69-2
- Vial
- 50 mg · 100 mg
AOD9604
≥99.0%Modified HGH fragment 176–191 (anti-obesity drug candidate)
- CAS
- 221231-10-3
- Vial
- 2 mg–10 mg
ARA-290 (Cibinetide)
≥99.0%EPO-derived 11-mer · cytoprotective research peptide
- CAS
- 1208243-50-8
- Vial
- 10 mg · 16 mg
27-mer
B7-33
≥99.0%Single-chain relaxin analog · RXFP1 agonist
- CAS
- 1818415-56-3
- Vial
- 2 mg · 10 mg
15-mer
BPC-157
≥99.0%Body Protection Compound 15-mer
- CAS
- 137525-51-0
- Vial
- 2 mg–10 mg
4-mer
Bronchogen
≥99.0%Khavinson bioregulator tetrapeptide (Ala-Glu-Asp-Leu, AEDL)
- CAS
- —
- Vial
- 20 mg
Cardiogen
≥99.0%Khavinson cardiovascular short-peptide bioregulator
- CAS
- —
- Vial
- 20 mg
Cartalax
≥99.0%Khavinson cartilage / connective-tissue bioregulator
- CAS
- —
- Vial
- 20 mg
Cerebrolysin
≥99.0%Neurotrophic peptide / protein-hydrolysate complex
- CAS
- —
- Vial
- 60 mg
CJC-1295 (no DAC)
≥99.0%Modified GRF 1-29 · GHRH analog
- CAS
- 863288-34-0
- Vial
- 2 mg–10 mg
CJC-1295 with DAC
≥99.0%Long-acting GHRH analog with Drug Affinity Complex
- CAS
- 863288-34-0
- Vial
- 2 mg · 5 mg
CJC-1295 + Ipamorelin
≥99.0%GH-axis blend (CJC-1295 no DAC + Ipamorelin)
- CAS
- —
- Vial
- 10 mg
4-mer
Cortagen
≥99.0%Khavinson cortical bioregulator tetrapeptide (Ala-Glu-Asp-Pro, AEDP)
- CAS
- —
- Vial
- 20 mg
Crystagen
≥99.0%Khavinson immune / endocrine short-peptide bioregulator
- CAS
- —
- Vial
- 20 mg
9-mer
DSIP
≥99.0%Delta sleep-inducing peptide
- CAS
- 62568-57-4
- Vial
- 2 mg–15 mg
4-mer
Epitalon
≥99.0%Pineal gland tetrapeptide
- CAS
- 307297-39-8
- Vial
- 10 mg · 50 mg
EPO (Erythropoietin)
≥99.0%Recombinant erythropoietin protein · heavily regulated
- CAS
- 11096-26-7
- Vial
- 3000 IU
FOXO4-DRI (FOX-04)
≥99.0%D-retro-inverso FOXO4 / p53 interaction blocker · senolytic peptide
- CAS
- 2460055-10-9
- Vial
- 2 mg · 10 mg
GHRP-2
≥99.0%Growth-hormone-releasing peptide-2 · Pralmorelin
- CAS
- 158861-67-7
- Vial
- 5 mg · 10 mg
GHRP-6
≥99.0%Growth-hormone-releasing peptide-6
- CAS
- 87616-84-0
- Vial
- 5 mg · 10 mg
HCG (Human Chorionic Gonadotropin)
≥99.0%Gonadotropin glycoprotein hormone · heavily regulated
- CAS
- 9002-61-3
- Vial
- 1000 IU–10 mg
HGH (Somatropin · Human Growth Hormone)
≥99.0%Recombinant human growth hormone · heavily regulated biological
- CAS
- 12629-01-5
- Vial
- 6 IU–40 IU
16-mer
HGH Fragment 176-191
≥99.0%C-terminal fragment of human growth hormone (176–191)
- CAS
- 66004-57-7
- Vial
- 1 mg–15 mg
HMG (Human Menopausal Gonadotropin / Menotropins)
≥99.0%FSH / LH-active gonadotropin · heavily regulated
- CAS
- 9002-68-0
- Vial
- 75 IU
IGF-1 LR3
≥99.0%Long-Arg3 IGF-1 (long-acting IGF-1 analog)
- CAS
- 946870-92-4
- Vial
- 100 mcg–2 mg
Ipamorelin
≥99.0%Ghrelin / GHSR pathway GH-release peptide
- CAS
- 170851-70-4
- Vial
- 2 mg–10 mg
Kisspeptin-10
≥99.0%Metastin (45-54) · HPG-axis research peptide
- CAS
- 374675-21-5
- Vial
- 5 mg · 10 mg
3-mer
KPV
≥99.0%Lys-Pro-Val α-MSH C-terminal tripeptide
- CAS
- 67727-97-3
- Vial
- 5 mg · 10 mg
LL-37
≥99.0%Cathelicidin antimicrobial peptide
- CAS
- 154947-66-7
- Vial
- 5 mg
Melanotan I (Afamelanotide)
≥99.0%α-MSH analog · approved for erythropoietic protoporphyria
- CAS
- 75921-69-6
- Vial
- 10 mg
Melanotan II (MT-II)
≥99.0%Melanocortin receptor agonist · regulated research peptide
- CAS
- 121062-08-6
- Vial
- 10 mg
Melatonin
≥99.0%Pineal hormone · sleep / circadian-rhythm research compound
- CAS
- 73-31-4
- Vial
- 10 mg
MGF (Mechano Growth Factor)
≥99.0%IGF-1 Ec splice-variant peptide
- CAS
- —
- Vial
- 2 mg
16-mer
MOTS-c
≥99.0%Mitochondrial-derived peptide
- CAS
- 1627580-64-6
- Vial
- 10 mg–40 mg
NAD+
≥99.0%Nicotinamide adenine dinucleotide
- CAS
- 53-84-9
- Vial
- 100 mg–1000 mg
28-mer
Oxytocin
≥99.0%Posterior-pituitary neuropeptide hormone · regulated
- CAS
- 50-56-6
- Vial
- 2 mg–10 mg
17-mer
P21 (P021)
≥99.0%CNTF-derived neurogenic tetrapeptide with adamantane moiety
- CAS
- —
- Vial
- 5 mg
PEG-MGF
≥99.0%PEGylated Mechano Growth Factor
- CAS
- 108174-48-7
- Vial
- 2 mg–10 mg
3-mer
Pinealon
≥99.0%Khavinson neuroprotective tripeptide (Glu-Asp-Arg, EDR)
- CAS
- 175175-23-2
- Vial
- 5 mg–20 mg
32-mer
PNC-27
≥99.0%p53-HDM2-binding · penetratin-fused research peptide
- CAS
- —
- Vial
- 10 mg
PROSTAMAX (Supplier Trade Name)
≥99.0%Supplier trade-name product · API to be confirmed
- CAS
- —
- Vial
- 20 mg
PT-141 (Bremelanotide)
≥99.0%Melanocortin-4 receptor agonist · approved for HSDD
- CAS
- 189691-06-3
- Vial
- 10 mg
7-mer
Selank
≥99.0%Tuftsin analog · anxiolytic research peptide
- CAS
- 129954-34-3
- Vial
- 5 mg · 10 mg
7-mer
Semax
≥99.0%ACTH 4-10 analog · cognitive research peptide
- CAS
- 80714-61-0
- Vial
- 2 mg–15 mg
29-mer
Sermorelin
≥99.0%GHRH 1-29 fragment
- CAS
- 86168-78-7
- Vial
- 2 mg–10 mg
SLU-PP-332
≥99.0%Pan-ERR agonist · exercise mimetic compound
- CAS
- 303760-60-3
- Vial
- 5 mg · 10 mg
SS-31 (Elamipretide)
≥99.0%Mitochondrial-targeted peptide
- CAS
- 736992-21-5
- Vial
- 5 mg–50 mg
43-mer
TB-500
≥99.0%Thymosin β4 fragment
- CAS
- 885340-08-9
- Vial
- 2 mg–10 mg
29-mer
Tesamorelin
≥99.0%GHRH analog · approved for HIV-associated lipodystrophy
- CAS
- 218949-48-5
- Vial
- 2 mg–20 mg
Thymalin / Thymulin
≥99.0%Thymic immune-modulation peptide(s)
- CAS
- 63958-90-7/ Thymalin extract, confirm via COA
- Vial
- 10 mg
28-mer
Thymosin Alpha-1 (Thymalfasin)
≥99.0%28-amino-acid thymic immune-modulation peptide
- CAS
- 62304-98-7
- Vial
- 5 mg · 10 mg
3-mer
Vesugen
≥99.0%Khavinson vascular tripeptide (Lys-Glu-Asp, KED)
- CAS
- —
- Vial
- 10 mg
VIP (Vasoactive Intestinal Peptide)
≥99.0%28-residue vasoactive / immune neuropeptide
- CAS
- 40077-57-4
- Vial
- 10 mg